An open resource for T cell phenotype changes in COVID-19 identifies IL-10-producing regulatory T cells as characteristic of severe cases

Julika Neumann, Teresa Prezzemolo, Lore Vanderbeke, Carlos P. Roca, Margaux Gerbaux, Silke Janssens, Mathijs Willemsen, Oliver T. Burton, Pierre Van Mol, Yannick Van Herck,

medRxiv · 2020 · 13 citations · 54 references

DOIFull text

Open access

Concepts

Abstract

Abstract The pandemic spread of the novel coronavirus SARS-CoV-2 is due, in part, to the immunological properties of the host-viral interaction. The clinical presentation varies greatly from individual to individual, with asymptomatic carriers, mild to moderate-presenting patients and severely affected patients. Variation in immune response to SARS-CoV-2 may underlie this clinical variation. Using a high dimensional systems immunology platform, we have analyzed the peripheral blood compartment of 6 healthy individuals, 23 mild-to-moderate COVID-19 patients and 20 severe COVID-19 patients. We identify distinct immunological signatures in the peripheral blood of the mild-to-moderate and severe COVID-19 patients, including T cell lymphopenia, more consistent with peripheral hypo-than hyper-immune activation. Unique to the severe COVID-19 cases was a large increase in the proportion of IL-10-secreting regulatory T cells, a lineage known to possess anti-inflammatory properties in the lung. Annotated data is openly available ( https://flowrepository.ors/experiments/2713 ) with clinical correlates, as a systems immunology resource for the COVID-19 research community.

References

54